Skip to main content
Premium Trial:

Request an Annual Quote

Unilabs to Distribute Mobidiag GI Infection MDx Products in Sweden, Norway

NEW YORK (GenomeWeb) – Diagnostics service provider Unilabs will offer Mobidiag's Amplidiag products in Sweden and Norway under a four-year agreement announced today.

The Amplidiag product line covers six diagnostic products for various gastrointestnal infections, including tests for gastroenteritis; carbapenem and vancomycin resistance; and non-invasive Helicobacter pylori testing. The products use well-established qPCR technology, Espoo, Finland-based Mobidiag said.

Unilabs is one of Europe's leading providers of clinical laboratory testing and medical diagnostic imaging services to private and public healthcare providers, local governments, insurance companies, pharmaceutical companies, and the general public. It operates laboratory and medical diagnostic imaging facilities in 12 countries.

"Implementing new multiplex molecular diagnostic tools is a step forward in our efforts to continuously improve our service portfolio and meet customer demands," Helena Enroth, head of R&D in molecular microbiology for Unilabs Sweden, said in a statement. "Mobidiag is able to offer a comprehensive suite for gastrointestinal testing, and importantly, the products meet our expectations for large-scale use."

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.